Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5916563 | Molecular Immunology | 2015 | 14 Pages |
Abstract
Complement is recognized as a key player in a wide range of normal as well as disease-related immune, developmental and homeostatic processes. Knowledge of complement components, structures, interactions, and cross-talk with other biological systems continues to grow and this leads to novel treatments for cancer, infectious, autoimmune- or age-related diseases as well as for preventing transplantation rejection. Antibodies are superbly suited to be developed into therapeutics with appropriate complement stimulatory or inhibitory activity. Here we review the design, development and future of antibody-based drugs that enhance or dampen the complement system.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Biology
Authors
Joost P.M. Melis, Kristin Strumane, Sigrid R. Ruuls, Frank J. Beurskens, Janine Schuurman, Paul W.H.I. Parren,